Petros Pharmaceuticals Inc (PTPI)
0.42
0.00 (0.00%)
USD |
NASDAQ |
Jun 17, 16:00
0.433
+0.01
(+3.10%)
After-Hours: 20:00
Petros Pharmaceuticals Total Liabilities (Quarterly): 19.62M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.62M |
| December 31, 2023 | 21.32M |
| September 30, 2023 | 31.86M |
| June 30, 2023 | 15.78M |
| March 31, 2023 | 15.12M |
| December 31, 2022 | 15.72M |
| September 30, 2022 | 17.00M |
| Date | Value |
|---|---|
| June 30, 2022 | 16.83M |
| March 31, 2022 | 20.14M |
| December 31, 2021 | 31.85M |
| September 30, 2021 | 34.19M |
| June 30, 2021 | 37.18M |
| March 31, 2021 | 45.23M |
| December 31, 2020 | 52.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.12M
Minimum
Mar 2023
52.38M
Maximum
Dec 2020
26.73M
Average
20.73M
Median
Total Liabilities (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 224.81M |
| Imunon Inc | 5.825M |
| iBio Inc | 25.29M |
| Ocugen Inc | 21.53M |
| Gritstone Bio Inc | 123.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.31M |
| Shareholders Equity (Quarterly) | 10.69M |
| Debt to Equity Ratio | 0.7494 |
| Current Ratio | 1.596 |
| Net Debt Paydown Yield | 2.87% |